Published on: June 17, 2019 at 09:30PM
Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Intervention: Drug: Faster-acting insulin aspart
Sponsor: Novo Nordisk A/S
Not yet recruiting
http://bit.ly/31CACW3
Monday, 17 June 2019
New diabetes clinical trial: An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.